APP and Alzheimer disease: “Resistance” refers to cases when the subject shows less than expected cognitive impairment, and less than expected amyloid beta peptide (Aβ) or hyperphosphorylated Tau protein (pTau) pathologies, despite a probable AD diagnosis.